Compare Incyte Corporation (INCY) vs Medtronic PLC (MDT) Price & Performance

Incyte CorporationTrade

Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Incyte Corporation vs Medtronic PLC — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Medtronic PLC trades at $82.79 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 4.6× Incyte Corporation's market cap, and Medtronic PLC pays a 3.46% dividend while Incyte Corporation pays none. Which is the better fit depends on your goals.

	INCY	MDT
Market Cap	$23.11B	$106.61B
Sector	Health	Health
52-Week High	$118.52	$105.35
52-Week Low	$67.38	$73.75
Enterprise Value	$19.13B	$125.36B
Dividend Yield	—	3.46%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INCY

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish View details →

MDT

Medtronic launches AI-powered Touch Surgery Aide for real-time support in robotic surgeries.PRNewsWire · 14 hours agoBullish Medtronic to report Q1 FY2027 financial results on September 1, 2026PRNewsWire · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Incyte Corporation

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.